超声、99mTc-甲氧基异丁基异腈与18F-氟胆碱PET/CT在原发性甲状旁腺功能亢进症患者甲状旁腺腺瘤检出中的效果比较
前瞻性纳入54例原发性甲状旁腺功能亢进症患者,术前分别行颈部超声、99mTc-甲氧基异丁基异腈(MIBI)显像(含或不含SPECT/CT)及18F-氟胆碱(FCH)PET/CT定位,以组织病理学为金标准。FCH PET/CT在患者水平和病灶水平分别检出52/54例和52/56个病灶,灵敏度和准确率均高于超声和MIBI。
要点
- FCH PET/CT患者水平灵敏度100%、阳性预测值96.3%、准确率96.3%,均高于超声和MIBI。
- 超声灵敏度69.3%、阳性预测值87.1%、准确率62.9%;MIBI分别为80.7%、97.6%、79.6%。
- 6例异位病灶中FCH PET/CT灵敏度与准确率均为100%,高于MIBI的66.6%和超声的16.7%。
核心结论
- 在同时测试的3种影像技术中,FCH PET/CT对甲状旁腺腺瘤的术前准确定位最优,尤其适用于异位或小甲状旁腺病灶。
研究设计与样本
- 前瞻性研究纳入54例连续的原发性甲状旁腺功能亢进症患者,术前使用3种诊断方法定位甲状旁腺病灶后接受手术。
- 以组织病理学为金标准,并结合术后生化反应确认,计算3种影像方法的灵敏度、阳性预测值和准确率。
主要发现
- FCH PET/CT在患者水平检出52/54例,在病灶水平检出52/56个组织病理学证实的甲状旁腺腺瘤。
- 术前超声、MIBI和FCH PET/CT分别定位异常甲状旁腺39例(72.2%)、43例(79.6%)和54例(100%)。
- 超声、MIBI和FCH PET/CT的灵敏度分别为69.3%、80.7%和100%,阳性预测值分别为87.1%、97.6%和96.3%。
- 患者水平分析中,超声、MIBI和FCH PET/CT的准确率分别为62.9%、79.6%和96.3%。
- 6例异位病灶患者中,FCH PET/CT的灵敏度和准确率高于MIBI和超声(100% vs 66.6%和16.7%)。
关键数值与推荐
- FCH PET/CT患者水平灵敏度100%、阳性预测值96.3%、准确率96.3%。
- MIBI患者水平灵敏度80.7%、阳性预测值97.6%、准确率79.6%。
- 超声患者水平灵敏度69.3%、阳性预测值87.1%、准确率62.9%。
- 异位病灶中FCH PET/CT灵敏度与准确率均为100%,MIBI为66.6%,超声为16.7%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Accurate preoperative localization of parathyroid lesion(s) is crucial for successful surgical management of primary hyperparathyroidism (PHPT). This study was conducted to compare the effectiveness of ultrasonography (USG) of the neck, Tc-sestamibi (MIBI) imaging with or without SPECT/CT, and F-fluorocholine (FCH) PET/CT imaging in the preoperative localization of parathyroid lesions in patients with PHPT. METHODS: Fifty-four consecutive patients with PHPT were included in this prospective study who underwent preoperative localization of the parathyroid lesion(s) using 3 diagnostic modalities followed by surgery. The sensitivity, positive predictive value, and accuracy of the 3 imaging procedures to accurately detect abnormal parathyroid glands were determined using histopathology as criterion standard with postoperative biochemical response confirmation. RESULTS: F-fluorocholine PET/CT detected 52 of 54 patients and 52 of 56 lesions with histopathologically proven parathyroid adenomas on patient-based and lesion-based analysis, respectively. Preoperative USG, MIBI, and FCH PET/CT localized abnormal parathyroid gland(s) in 39 (72.2%), 43 (79.6%), and 54 (100%) patients, respectively. The sensitivity and positive predictive value were 69.3% and 87.1% for USG, 80.7% and 97.6% for MIBI, and 100% and 96.3% for FCH PET/CT. The accuracy was 62.9%, 79.6%, and 96.3% for USG, MIBI, and FCH PET/CT, respectively, in patient-wise analysis. In 6 patients with ectopic lesions, FCH PET/CT demonstrated higher sensitivity and accuracy than MIBI and USG (100% vs 66.6% and 16.7%, respectively). CONCLUSIONS: Among the 3 imaging techniques tested simultaneously, FCH PET/CT was superior for accurate preoperative localization of parathyroid adenomas, especially for ectopic or small parathyroid lesions.
引用
- Thanseer N, Bhadada SK, Sood A, et al. Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism. Clin Nucl Med. 2017. PMID: 28902729. doi:10.1097/RLU.0000000000001845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。